Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
|
|
50.
|
|
|
51.
|
|
|
52.
|
|
|
53.
|
An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. [electronic resource] by
- Schönfeld, D
- Matschiner, G
- Chatwell, L
- Trentmann, S
- Gille, H
- Hülsmeyer, M
- Brown, N
- Kaye, P M
- Schlehuber, S
- Hohlbaum, A M
- Skerra, A
Producer: 20090623
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 106
Availability: No items available.
|
|
54.
|
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis. [electronic resource] by
- Moreno, J
- Nieto, J
- Masina, S
- Cañavate, C
- Cruz, I
- Chicharro, C
- Carrillo, E
- Napp, S
- Reymond, C
- Kaye, P M
- Smith, D F
- Fasel, N
- Alvar, J
Producer: 20070911
In:
Vaccine vol. 25
Availability: No items available.
|